Ifedayo Victor Ogungbe to Animals
This is a "connection" page, showing publications Ifedayo Victor Ogungbe has written about Animals.
Connection Strength
0.528
-
Adeyinka OS, Barrera MD, Metibemu DS, Boghdeh N, Anderson CA, Baha H, Crown O, Falode JA, Bleach JL, Bliss AR, Hampton TP, Ojobor JC, Alem F, Narayanan A, Ogungbe IV. nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in Mice. ACS Infect Dis. 2025 Jan 10; 11(1):181-196.
Score: 0.068
-
Brai BIC, Joseph RO, Komolafe TR, Amosun BE, Crown OO, Komolafe K, Ogungbe IV. Neem seed oil ameliorates diabetic phenotype by suppressing redox imbalance, dyslipidaemia and pro-inflammatory mediators in a rodent model of type 2 diabetes. Arch Physiol Biochem. 2025 Jun; 131(3):351-365.
Score: 0.067
-
Metibemu DS, Adeyinka OS, Falode J, Hampton T, Crown O, Ojobor JC, Narayanan A, Julander J, Ogungbe IV. Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya. Eur J Med Chem. 2024 Nov 15; 278:116808.
Score: 0.066
-
Metibemu DS, Adeyinka OS, Falode J, Crown O, Ogungbe IV. Inhibitors of the Structural and Nonstructural Proteins of Alphaviruses. ACS Infect Dis. 2024 08 09; 10(8):2507-2524.
Score: 0.066
-
Ajayi O, Metibemu DS, Crown O, Adeyinka OS, Kaiser M, Shoji N, Silva M, Rodriguez A, Ogungbe IV. Discovery of an orally active nitrothiophene-based antitrypanosomal agent. Eur J Med Chem. 2024 Jan 05; 263:115954.
Score: 0.063
-
Metibemu DS, Ogungbe IV. Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases. Molecules. 2022 Sep 15; 27(18).
Score: 0.058
-
Ogungbe IV, Setzer WN. Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Molecules. 2009 Apr 14; 14(4):1513-36.
Score: 0.023
-
Komolafe K, Komolafe TR, Crown OO, Ajiboye B, Noubissi F, Ogungbe IV, Graham B. Natural Products in the Management of Gastroesophageal Reflux Disease: Mechanisms, Efficacy, and Future Directions. Nutrients. 2025 Mar 19; 17(6).
Score: 0.017
-
Coy-Barrera E, Ogungbe IV, Schmidt TJ. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Therapeutics. Molecules. 2023 Apr 25; 28(9).
Score: 0.015
-
Boghdeh NA, McGraw B, Barrera MD, Anderson C, Baha H, Risner KH, Ogungbe IV, Alem F, Narayanan A. Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses. Viruses. 2023 02 28; 15(3).
Score: 0.015
-
Santos CC, Zhang H, Batista MM, de Oliveira GM, Demarque KC, da Silva NL, Moreira OC, Ogungbe IV, Soeiro MNC. Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1H-imidazoyl-based compounds as antileishmanial agents. Parasitology. 2022 04; 149(4):490-495.
Score: 0.014
-
Ilesanmi OB, Akinmoladun AC, Elusiyan CA, Ogungbe IV, Olugbade TA, Olaleye MT. Neuroprotective flavonoids of the leaf of Antiaris africana Englea against cyanide toxicity. J Ethnopharmacol. 2022 Jan 10; 282:114592.
Score: 0.013
-
Santos CC, Zhang H, Batista MM, de Oliveira GM, Demarque KC, da Silva-Gomes NL, Moreira OC, Ogungbe IV, Soeiro MNC. In Vitro and In Vivo Evaluation of an Adamantyl-Based Phenyl Sulfonyl Acetamide against Cutaneous Leishmaniasis Models of Leishmania amazonensis. Antimicrob Agents Chemother. 2020 11 17; 64(12).
Score: 0.013
-
Harrison N, Lone MA, Kaul TK, Reis Rodrigues P, Ogungbe IV, Gill MS. Characterization of N-acyl phosphatidylethanolamine-specific phospholipase-D isoforms in the nematode Caenorhabditis elegans. PLoS One. 2014; 9(11):e113007.
Score: 0.008
-
Kaul TK, Reis Rodrigues P, Ogungbe IV, Kapahi P, Gill MS. Bacterial fatty acids enhance recovery from the dauer larva in Caenorhabditis elegans. PLoS One. 2014; 9(1):e86979.
Score: 0.008
-
Schmidt TJ, Khalid SA, Romanha AJ, Alves TM, Biavatti MW, Brun R, Da Costa FB, de Castro SL, Ferreira VF, de Lacerda MV, Lago JH, Leon LL, Lopes NP, das Neves Amorim RC, Niehues M, Ogungbe IV, Pohlit AM, Scotti MT, Setzer WN, de N C Soeiro M, Steindel M, Tempone AG. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I. Curr Med Chem. 2012; 19(14):2128-75.
Score: 0.007
-
Schmidt TJ, Khalid SA, Romanha AJ, Alves TM, Biavatti MW, Brun R, Da Costa FB, de Castro SL, Ferreira VF, de Lacerda MV, Lago JH, Leon LL, Lopes NP, das Neves Amorim RC, Niehues M, Ogungbe IV, Pohlit AM, Scotti MT, Setzer WN, de N C Soeiro M, Steindel M, Tempone AG. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II. Curr Med Chem. 2012; 19(14):2176-228.
Score: 0.007